Traumatic Brain Injury is another major treatment market targeted by psychedelics R&D. TBIs are now a health crisis in many professional sports. Opportunity knocks.
Traumatic Brain Injury is another major treatment market targeted by psychedelics R&D. TBIs are now a health crisis in many professional sports. Opportunity knocks.
For a solid month, there has been an explosion in coverage of the psychedelic drug industry by the mainstream media.
Psychedelic drug stocks are a very progressive investing option for investors seeking high-growth opportunities. So why aren't more Millennials jumping on the bandwagon?
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Psychedelic stocks have become extremely concentrated -- like other sectors. Here's why we see that changing in this sector.
MindMed Inc has become the first psychedelics company to successfully uplist to the NASDAQ. Who will be the second...???
In 2020, investors were able to reap spectacular returns from psychedelic stock warrants. With a new rally starting in the sector, a there is a NEW opportunity in these warrants.
U.S. support for legalizing cannabis for medicinal use has hit a new record-high: 91%. Strong bipartisan support. Next: psychedelic drugs.
With atai Life Sciences filing for a $100 million IPO financing, the countdown to IPO day has begun.
Low share prices. VERY low trading volumes. The slump in psychedelic stocks in 2021 looks a lot like the slump in 2020.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now